These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 5479089)
21. [Should older patients with PKU be diet treated?]. Hambraeus L; Holmgren G; Samuelson G Lakartidningen; 1974 Mar; 71(12):1183-4. PubMed ID: 4821509 [No Abstract] [Full Text] [Related]
22. [Treatment of phenylketonuria. Principles, management and importance of a phenylalanine-free protein hydrolysate]. Boisse J; Saudubray JM; Cathy T; Mozziconacci P Ann Pediatr (Paris); 1971 Feb; 18(2):109-17. PubMed ID: 5549952 [No Abstract] [Full Text] [Related]
23. Screening tests for phenylketonuria. Br Med J; 1968 Mar; 1(5593):656-7. PubMed ID: 5640642 [No Abstract] [Full Text] [Related]
24. [Phenylketonuria. Diagnosis, principles of the dietetic treatment and practical applications]. Costil J; Richardet JM; Brissaud HE Rev Prat; 1972 Feb; 22(6):793-802. PubMed ID: 5064411 [No Abstract] [Full Text] [Related]
25. The newborn phenylketonuria screening program in Ontario. Can Med Assoc J; 1969 Aug; 101(4):185-90. PubMed ID: 5811698 [No Abstract] [Full Text] [Related]
26. Evaluation of the effects of terminating the diet in phenylketonuria. Solomons G; Keleske L; Opitz E J Pediatr; 1966 Oct; 69(4):596-602. PubMed ID: 5921335 [No Abstract] [Full Text] [Related]
27. Termination of dietary treatment of phenylketonuria. Murphy D Ir J Med Sci; 1969 Apr; 8(4):177-83. PubMed ID: 5802163 [No Abstract] [Full Text] [Related]
28. [Clinical and metabolic conrbution to the nosologic classification of hyperphenylalaninemias]. Porro G; Ammaniti M Sist Nerv; 1968; 20(2):110-7. PubMed ID: 5735835 [No Abstract] [Full Text] [Related]
29. [Assessment of cerebral bioelectric activity in children with phenylketonuria treated past the age of 6 months]. Koslacz-Folga A; Cabalska B; Jackowksa K Neurol Neurochir Pol; 1972; 6(5):823-9. PubMed ID: 4655987 [No Abstract] [Full Text] [Related]
30. [Our experience with the diet therapy of phenylketonuria using the phenylalanine-free preparation Albumaid XP]. Hyánek J; Viletová H; Hoza J; Rónová R; Pĕtová J Cesk Pediatr; 1970 Aug; 25(8):397-400. PubMed ID: 5454637 [No Abstract] [Full Text] [Related]
34. [The incidence of phenylketonuria and the evaluation of its early treatment]. Cabalska B; Duczyńska N; Wnuk W Neurol Neurochir Pol; 1969; 3(3):315-21. PubMed ID: 5803009 [No Abstract] [Full Text] [Related]
35. [Phenylketonuria. 3. Evaluation of early treatment]. Cabalska B; Duczyńska N Pediatr Pol; 1969 Aug; 44(8):933-41. PubMed ID: 4310011 [No Abstract] [Full Text] [Related]
36. [On 4 cases of phenylketonuria maintained on a low-phenylalanine diet. II. Clinical aspects and treatment]. Bartolozzi G; Vierucci A Riv Clin Pediatr; 1964 Dec; 74(6):588-99. PubMed ID: 5853461 [No Abstract] [Full Text] [Related]
37. The depressing effect of diet on physical growth in phenylketonuria. Sibinga MS; Friedman CJ; Steisel IM; Baker EC Dev Med Child Neurol; 1971 Feb; 13(1):63-70. PubMed ID: 5554951 [No Abstract] [Full Text] [Related]
39. [The action of fever on phenylalanine blood levels in phenylketonuric patients undergoing treatment]. Bartolozzi G; Corvaglia E Minerva Pediatr; 1967 Aug; 19(34):1577-8. PubMed ID: 5610731 [No Abstract] [Full Text] [Related]
40. [Effect of late use of diet therapy in a child with phenylketonuria]. Kirsig HJ; Maisch H Monatsschr Kinderheilkd (1902); 1969 Jan; 117(1):38-40. PubMed ID: 5398917 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]